Buyback yield (TTM)
4.54%
Shareholder yield (TTM)
4.91%
5Y share count change
-5.5%
Buyback spend (TTM)
$8.00B
Cumulative buybacks
$28.60B
Key takeaways
- Thermo Fisher Scientific (TMO) repurchased about $8.00B of stock over the trailing twelve months.
- Diluted share count is down 5.5% over the last ~5 fiscal years — buybacks are net-shrinking the share base.
- TTM buyback ÷ stock-based-comp ratio of 95.24× — repurchases more than cover SBC dilution.
- Cash buyback spend has compounded at +14.9% per year over the latest 5-year window.
- TTM repurchases used about 131% of free cash flow remaining after dividends.
Dividend & buyback yield over time for Thermo Fisher Scientific (TMO)
Stacked annual yields — buyback yield (TTM cash repurchases ÷ market cap) plus dividend yield from the same fiscal-year-end key-metrics period — show how total cash return per dollar of equity has evolved.
Diluted vs basic shares (annual) for Thermo Fisher Scientific (TMO)
Diluted weighted-average shares are the EPS denominator — a falling count means buybacks are outpacing SBC dilution.
Year-over-year change in diluted shares for Thermo Fisher Scientific (TMO)
Green is fewer shares vs the prior fiscal year (net repurchase); red is growth (dilution). The earliest year shown has no prior year to compare.
Cash buyback spend over time for Thermo Fisher Scientific (TMO)
Latest: $3.00B
Overview
The 2025 reading of Thermo Fisher Scientific (TMO) buyback spend is $3.00B – declined 25.0% year-over-year.
Over 2020–2025 (5 years), Thermo Fisher Scientific buyback spend expanded at a +14.9% compound annual rate, with mixed annual results across the window.
Thermo Fisher Scientific buyback spend peaked at $4.00B in 2024; the latest annual figure is $3.00B in 2025 (25.0% below peak).
The highest annual buyback spend of $4.00B was reported in 2024. The lowest in the available history was $0.00 in 2000.
Thermo Fisher Scientific Buyback Spend 2025: $3.00B
Thermo Fisher Scientific buyback spend in 2025 was $3.00B, declined 25.0% below 2024.
Thermo Fisher Scientific Buyback Spend 2024: $4.00B
2024's buyback spend for Thermo Fisher Scientific came in at $4.00B, surged 33.3% from 2023. This figure represents the highest annual value in the available history.
Thermo Fisher Scientific Buyback Spend 2023: $3.00B
Thermo Fisher Scientific posted buyback spend of $3.00B in 2023, edged up 0.0% from 2022.
Thermo Fisher Scientific Buyback Spend 2022: $3.00B
In 2022, Thermo Fisher Scientific reported buyback spend of $3.00B, surged 50.0% from 2021.
Thermo Fisher Scientific Buyback Spend 2021: $2.00B
Thermo Fisher Scientific buyback spend in 2021 was $2.00B.
See more financial history for Thermo Fisher Scientific (TMO).
Buyback, SBC & dilution history
Buyback spend, SBC, net dilution effect, and share count.
| 2025 | $3.00B | $310.00M | $2.69B | 1.38% | 0.38B | -1.6% | |
| 2024 | $4.00B | $301.00M | $3.70B | 2.01% | 0.38B | -1.3% | |
| 2023 | $3.00B | $278.00M | $2.72B | 1.46% | 0.39B | -1.5% | |
| 2022 | $3.00B | $307.00M | $2.69B | 1.39% | 0.39B | -0.8% | |
| 2021 | $2.00B | $230.00M | $1.77B | 0.76% | 0.40B | -0.5% | |
| 2020 | $1.50B | $196.00M | $1.30B | 0.81% | 0.40B | -1.0% | |
| 2019 | $1.50B | $181.00M | $1.32B | 1.16% | 0.40B | -0.7% | |
| 2018 | $500.00M | $181.00M | $319.00M | 0.56% | 0.41B | +2.0% | |
| 2017 | $750.00M | $159.00M | $591.00M | 0.99% | 0.40B | +0.2% | |
| 2016 | $1.25B | $133.50M | $1.12B | 2.25% | 0.40B | -1.1% | |
| 2015 | $500.00M | $125.00M | $375.00M | 0.88% | 0.40B | -0.1% | |
| 2014 | $0.00 | $117.10M | −$117.10M | — | 0.40B | +10.0% | |
| 2013 | $89.80M | $90.90M | −$1.10M | 0.22% | 0.37B | -0.2% | |
| 2012 | $1.15B | $78.20M | $1.07B | 5.04% | 0.37B | -4.7% | |
| 2011 | $1.34B | $80.20M | $1.26B | 7.97% | 0.38B | -6.0% | |
| 2010 | $1.01B | $83.10M | $929.40M | 4.71% | 0.41B | -3.2% | |
| 2009 | $414.60M | $68.10M | $346.50M | 2.12% | 0.42B | -2.7% | |
| 2008 | $187.40M | $57.10M | $130.30M | 1.32% | 0.43B | -2.0% | |
| 2007 | $898.00M | $51.10M | $846.90M | 3.73% | 0.44B | +117.8% | |
| 2006 | $300.00M | $1.76M | $298.24M | 1.58% | 0.20B | +23.2% | |
| 2005 | $0.00 | $0.00 | $0.00 | — | 0.17B | -1.4% | |
| 2004 | $0.00 | $0.00 | $0.00 | — | 0.17B | -1.8% | |
| 2003 | $88.87M | $0.00 | $88.87M | 2.13% | 0.17B | -4.6% | |
| 2002 | $334.15M | $0.00 | $334.15M | 10.20% | 0.18B | -3.2% | |
| 2001 | $511.39M | $0.00 | $511.39M | 12.30% | 0.19B | +12.7% | |
| 2000 | $0.00 | $0.00 | $0.00 | — | 0.16B | +3.7% | |
| 1999 | $190.40M | $0.00 | $190.40M | — | 0.16B | -6.1% | |
| 1998 | $470.60M | $0.00 | $470.60M | — | 0.17B | -0.8% | |
| 1997 | $121.60M | $0.00 | $121.60M | — | 0.17B | -3.4% | |
| 1996 | $140.90M | $0.00 | $140.90M | — | 0.18B | — | |
| 1995 | $97.80M | $0.00 | $97.80M | — | — | — | |
| 1994 | $101.50M | $0.00 | $101.50M | — | — | — | |
| 1993 | $57.20M | $0.00 | $57.20M | — | — | — | |
| 1992 | $45.30M | $0.00 | $45.30M | — | — | — | |
| 1991 | $11.70M | $0.00 | $11.70M | — | — | — | |
| 1990 | $26.50M | $0.00 | $26.50M | — | — | — | |
| 1989 | $8.10M | $0.00 | $8.10M | — | — | — |
- 2025$3.00B
- 2024$4.00B
- 2023$3.00B
- 2022$3.00B
- 2021$2.00B
- 2020$1.50B
- 2019$1.50B
- 2018$500.00M
- 2017$750.00M
- 2016$1.25B
- 2015$500.00M
- 2014$0.00
- 2013$89.80M
- 2012$1.15B
- 2011$1.34B
- 2010$1.01B
- 2009$414.60M
- 2008$187.40M
- 2007$898.00M
- 2006$300.00M
- 2005$0.00
- 2004$0.00
- 2003$88.87M
- 2002$334.15M
- 2001$511.39M
- 2000$0.00
- 1999$190.40M
- 1998$470.60M
- 1997$121.60M
- 1996$140.90M
- 1995$97.80M
- 1994$101.50M
- 1993$57.20M
- 1992$45.30M
- 1991$11.70M
- 1990$26.50M
- 1989$8.10M
Buybacks vs stock-based compensation for Thermo Fisher Scientific (TMO)
Annual cash repurchases set against stock-based compensation. Coverage above 1× means buybacks fully offset the equity dilution from SBC. TTM coverage: 95.24×.
Buybacks vs dividends (share of cash returned) for Thermo Fisher Scientific (TMO)
How Thermo Fisher Scientific splits cash returned to shareholders between dividends and buybacks.
Sector peers by buyback spend
Companies in the same sector as Thermo Fisher Scientific, ranked by their latest buyback spend.
| $5.95B | |
| $5.54B | |
| $5.08B | |
| $4.11B | |
| $980.00M | |
| $216.35M | |
| $0.00 | |
| $0.00 |
- $5.95B
- $5.54B
- $5.08B
- $4.11B
- $980.00M
- $216.35M
- $0.00
- $0.00
Buyback capacity (TTM)
Free cash flow minus dividends paid versus actual TTM repurchases — the headroom bar shows how much of post-dividend FCF is still being deployed elsewhere.
Headroom $6.10B (TTM FCF − TTM dividends, clamped at zero).
Frequently asked questions
Data & methodology
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation